Gene Williams is the Executive Chairman of ProMIS Neurosciences, a publicly traded biotech focused on therapy development for Alzheimer’s disease. As former Senior Vice President of Program and Portfolio Management at Genzyme, Gene comes to SHEPHERD with expert knowledge on commercialization integration, drug development, and deal making. Prior to his time at Genzyme, Williams worked as a consultant at Bain & Company and Corporate Decisions Inc., where he served as co-Head of Healthcare focused on commercialization strategies and on speeding and improving the drug development process. Gene most recently co-founded and acted as CEO of Dart Therapeutics, an orphan disease drug development company determined to improve clinical trial efficiency and maximize investor resources. Eugene holds a B.A. from Harvard University and an M.B.A. from Harvard Business School.
Gene is an avid guitar player, biker, and gourmet cook although usually not at the same time.